Neuroleptic-sensitive binding sites in the nigrostriatal system: evidence for differential distribution of sigma sites in the substantia nigra, pars compacta of the cat - PubMed (original) (raw)
Neuroleptic-sensitive binding sites in the nigrostriatal system: evidence for differential distribution of sigma sites in the substantia nigra, pars compacta of the cat
A M Graybiel et al. J Neurosci. 1989 Jan.
Abstract
The sigma site is a recently described binding site to which dextrorotary isomers of certain psychotomimetic benzomorphans bind specifically. Classical and nonclassical neuroleptics also have high affinity for the sigma site, including neuroleptics known to bind to the D2 dopamine receptor. The affinity of some D2-binding neuroleptics for the sigma site has raised the possibility that certain important effects of antipsychotic drugs may relate to the sigma site. Left unresolved has been the question of how these actions could relate to dopaminergic systems. To explore this issue we carried out an autoradiographic binding study of the distribution of the sigma-selective ligand 3H-DTG in the nigrostriatal system. We report here that haloperidol-displaceable 3H-DTG binding sites are densely concentrated in an anatomically discrete subdivision of the cat's substantia nigra pars compacta. This zone, identifiable as the striosome-projecting densocellular zone of the pars compacta, also shows heightened D2-related ligand binding but has reduced D1-related ligand binding relative to other parts of the nigral complex. This evidence suggests that sigma-mediated interactions with dopaminergic systems may occur in the substantia nigra pars compacta and that the functional effects of these interactions may influence the nigrostriatal projection to striosomes differentially.
Similar articles
- Subdivisions of the dopamine-containing A8-A9-A10 complex identified by their differential mesostriatal innervation of striosomes and extrastriosomal matrix.
Jimenez-Castellanos J, Graybiel AM. Jimenez-Castellanos J, et al. Neuroscience. 1987 Oct;23(1):223-42. doi: 10.1016/0306-4522(87)90285-5. Neuroscience. 1987. PMID: 3683862 - [Paradigm of negative feedback via long-loop in the striatal dopamine release modulation in the rat].
Bueno-Nava A, Gonzalez-Pina R, Avila-Luna A, Alfaro-Rodriguez A. Bueno-Nava A, et al. Rev Neurol. 2011 Mar 16;52(6):371-7. Rev Neurol. 2011. PMID: 21387254 Review. Spanish.
Cited by
- Pharmacological comparison of the sigma recognition site labelled by [3H]haloperidol in human and rat cerebellum.
Barnes JM, Barnes NM, Barber PC, Champaneria S, Costall B, Hornsby CD, Ironside JW, Naylor RJ. Barnes JM, et al. Naunyn Schmiedebergs Arch Pharmacol. 1992 Feb;345(2):197-202. doi: 10.1007/BF00165736. Naunyn Schmiedebergs Arch Pharmacol. 1992. PMID: 1314960 - Regulating ankyrin dynamics: Roles of sigma-1 receptors.
Hayashi T, Su TP. Hayashi T, et al. Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):491-6. doi: 10.1073/pnas.98.2.491. Epub 2001 Jan 9. Proc Natl Acad Sci U S A. 2001. PMID: 11149946 Free PMC article. - BMY-14802 reverses the reduction of striatal dopamine release induced by (+)-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine.
Kanzaki A, Okumura K, Ujike H, Tsuchida K, Akiyama K, Otsuki S. Kanzaki A, et al. J Neural Transm Gen Sect. 1992;90(2):137-44. doi: 10.1007/BF01250795. J Neural Transm Gen Sect. 1992. PMID: 1361127 - Calcium-dependent, D2 receptor-independent induction of c-fos by haloperidol in dopamine neurons.
Jomphe C, Lévesque D, Trudeau LE. Jomphe C, et al. Naunyn Schmiedebergs Arch Pharmacol. 2003 May;367(5):480-9. doi: 10.1007/s00210-003-0742-3. Epub 2003 Apr 15. Naunyn Schmiedebergs Arch Pharmacol. 2003. PMID: 12695877 - Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry.
Debonnel G. Debonnel G. J Psychiatry Neurosci. 1993 Jul;18(4):157-72. J Psychiatry Neurosci. 1993. PMID: 8373754 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous